Skip to main content

Advertisement

Log in

Affective symptom dimensions in early-onset psychosis over time: a principal component factor analysis of the Young Mania Rating Scale and the Hamilton Depression Rating Scale

  • Original Contribution
  • Published:
European Child & Adolescent Psychiatry Aims and scope Submit manuscript

Abstract

Early-onset psychosis (EOP) is a complex disorder characterized by a wide range of symptoms, including affective symptoms. Our aim was to (1) examine the dimensional structure of affective symptoms in EOP, (2) evaluate the predominance of the clinical dimensions and (3) assess the progression of the clinical dimensions over a 2-year period. STROBE-compliant prospective principal component factor analysis of Young Mania Rating Scale (YMRS) and Hamilton Depression Rating Scale-21 (HDRS-21) at baseline, 6-months, 1-year and 2-year follow-up. We included 108 EOP individuals (mean age = 15.5 ± 1.8 years, 68.5% male). The factor analysis produced a four-factor model including the following dimensions: mania, depression/anxiety, sleep and psychosis. It explained 47.4% of the total variance at baseline, 60.6% of the total variance at 6-months follow-up, 54.5% of the total variance at 1-year follow-up and 49.5% of the total variance at 2-year follow-up. According to the variance explained, the mania factor was predominant at baseline (17.4%), 6-month follow-up (23.5%) and 2-year follow-up (26.1%), while the depression/anxiety factor was predominant at 1-year follow-up (23.1%). The mania factor was the most stable; 58.3% items that appeared in this factor (with a load > 0.4) at any time point appeared in the same factor at ≥ 3/4 time points. Affective symptoms are frequent and persistent in EOP. Mania seems to be the most predominant and stable affective dimension. However, depression and anxiety may gain predominance with time. A comprehensive evaluation of the dimensional structure and the progression of affective symptoms may offer clinical and therapeutic advantages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. van Os J, Kapur S (2009) Schizophrenia. Lancet 374(9690):635–645

    Article  Google Scholar 

  2. Arango C, Fraguas D, Parellada M (2014) Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders. Schizophr Bull 40(Suppl 2):S138–S146

    Article  Google Scholar 

  3. Arango C (2015) First-episode psychosis research: time to move forward (by looking backwards). Schizophr Bull 41(6):1205–1206

    Article  Google Scholar 

  4. Pillinger T, D’Ambrosio E, McCutcheon R, Howes OD (2019) Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models. Mol Psychiatry 24(6):776–794

    Article  CAS  Google Scholar 

  5. Rapado-Castro M, Soutullo C, Fraguas D, Arango C, Payá B, Castro-Fornieles J et al (2010) Predominance of symptoms over time in early-onset psychosis: a principal component factor analysis of the Positive and Negative Syndrome Scale. J Clin Psychiatry 71(3):327–337

    Article  Google Scholar 

  6. Stentebjerg-Olesen M, Pagsberg AK, Fink-Jensen A, Correll CU, Jeppesen P (2016) Clinical characteristics and predictors of outcome of schizophrenia-spectrum psychosis in children and adolescents: a systematic review. J Child Adolesc Psychopharmacol 26(5):410–427

    Article  Google Scholar 

  7. Kao YC, Liu YP (2010) Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders. BMC Psychiatry 10:63

    Article  Google Scholar 

  8. Díaz-Caneja CM, Pina-Camacho L, Rodríguez-Quiroga A, Fraguas D, Parellada M, Arango C (2015) Predictors of outcome in early-onset psychosis: a systematic review. NPJ Schizophr 1:14005

    Article  Google Scholar 

  9. Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T (2013) Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ 346:f185

    Article  Google Scholar 

  10. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders. Washington, DC

  11. World Health Organization (2019) International Classification of Diseases 11th Revision, 2019 [updated 4/2019. ICD-11. https://icd.who.int/browse11

  12. Grover S, Dua D, Chakrabarti S, Avasthi A (2018) Factor analysis of symptom dimensions (psychotic, affective and obsessive compulsive symptoms) in schizophrenia. Asian J Psychiatry 38:72–77

    Article  Google Scholar 

  13. Wilson S, Sponheim SR (2014) Dimensions underlying psychotic and manic symptomatology: extending normal-range personality traits to schizophrenia and bipolar spectra. Compr Psychiatry 55(8):1809–1819

    Article  Google Scholar 

  14. van Os J, Tamminga C (2007) Deconstructing psychosis. Schizophr Bull 33(4):861–862

    Article  Google Scholar 

  15. Petruzzelli MG, Margari L, Bosco A, Craig F, Palumbi R, Margari F (2018) Early onset first episode psychosis: dimensional structure of symptoms, clinical subtypes and related neurodevelopmental markers. Eur Child Adolesc Psychiatry 27(2):171–179

    Article  Google Scholar 

  16. Ajnakina O, Lally J, Di Forti M, Stilo SA, Kolliakou A, Gardner-Sood P et al (2018) Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosis. Schizophr Res 193:391–398

    Article  Google Scholar 

  17. Barch DM, Bustillo J, Gaebel W, Gur R, Heckers S, Malaspina D et al (2013) Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5. Schizophr Res 150(1):15–20

    Article  Google Scholar 

  18. Valle R (2020) Schizophrenia in ICD-11: comparison of ICD-10 and DSM-5. Rev Psiquiatr Salud Ment 13(2):95–104

    Article  Google Scholar 

  19. Li W, Yang Y, An FR, Zhang L, Ungvari GS, Jackson T et al (2020) Prevalence of comorbid depression in schizophrenia: a meta-analysis of observational studies. J Affect Disord 273:524–531

    Article  Google Scholar 

  20. Arrasate M, González-Ortega I, García-Alocén A, Alberich S, Zorrilla I, González-Pinto A (2016) Prognostic value of affective symptoms in first-admission psychotic patients. Int J Mol Sci 17(7):1039

    Article  Google Scholar 

  21. Lindenmayer JP, Bernstein-Hyman R, Grochowski S (1994) A new five factor model of schizophrenia. Psychiatr Q 65(4):299–322

    Article  CAS  Google Scholar 

  22. Arrasate M, González-Ortega I, Alberich S, Gutierrez M, Martínez-Cengotitabengoa M, Mosquera F et al (2014) Affective dimensions as a diagnostic tool for bipolar disorder in first psychotic episodes. Eur Psychiatry 29(7):424–430

    Article  CAS  Google Scholar 

  23. Russo M, Levine SZ, Demjaha A, Di Forti M, Bonaccorso S, Fearon P et al (2014) Association between symptom dimensions and categorical diagnoses of psychosis: a cross-sectional and longitudinal investigation. Schizophr Bull 40(1):111–119

    Article  Google Scholar 

  24. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R et al (1990) SCAN. schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 47(6):589–593

    Article  CAS  Google Scholar 

  25. Scharfetter C (1983) The psychopathological background of the AMDP-system. Mod Probl Pharmacopsychiatry 20:46–54

    Article  CAS  Google Scholar 

  26. Cuesta MJ, Peralta V (2001) Integrating psychopathological dimensions in functional psychoses: a hierarchical approach. Schizophr Res 52(3):215–229

    Article  CAS  Google Scholar 

  27. Caletti E, Delvecchio G, Andreella A, Finos L, Perlini C, Tavano A et al (2018) Prosody abilities in a large sample of affective and non-affective first episode psychosis patients. Compr Psychiatry 86:31–38

    Article  Google Scholar 

  28. van Os J, Gilvarry C, Bale R, van Horn E, Tattan T, White I et al (2000) Diagnostic value of the DSM and ICD categories of psychosis: an evidence-based approach. Soc Psychiatry Psychiatr Epidemiol 35(7):305–311

    Article  Google Scholar 

  29. Fraguas D, de Castro MJ, Medina O, Parellada M, Moreno D, Graell M et al (2008) Does diagnostic classification of early-onset psychosis change over follow-up? Child Psychiatry Hum Dev 39(2):137–145

    Article  Google Scholar 

  30. Castro-Fornieles J, Baeza I, de la Serna E, Gonzalez-Pinto A, Parellada M, Graell M et al (2011) Two-year diagnostic stability in early-onset first-episode psychosis. J Child Psychol Psychiatry 52(10):1089–1098

    Article  Google Scholar 

  31. Sanchez-Gistau V, Baeza I, Arango C, González-Pinto A, de la Serna E, Parellada M et al (2015) The affective dimension of early-onset psychosis and its relationship with suicide. J Child Psychol Psychiatry 56(7):747–755

    Article  Google Scholar 

  32. Zeschel E, Correll CU, Haussleiter IS, Krüger-Özgürdal S, Leopold K, Pfennig A et al (2013) The bipolar disorder prodrome revisited: Is there a symptomatic pattern? J Affect Disord 151(2):551–560

    Article  Google Scholar 

  33. Correll CU, Penzner JB, Frederickson AM, Richter JJ, Auther AM, Smith CW et al (2007) Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome. Schizophr Bull 33(3):703–714

    Article  Google Scholar 

  34. Van Eck RM, Burger TJ, Schenkelaars M, Vellinga A, de Koning MB, Schirmbeck F et al (2018) The impact of affective symptoms on personal recovery of patients with severe mental illness. Int J Soc Psychiatry 64(6):521–527

    Article  Google Scholar 

  35. Peralta V, Cuesta MJ (2009) Characterization of affective domains within the nonaffective psychotic disorders. Schizophr Res 111(1–3):61–69

    Article  Google Scholar 

  36. González-Pinto A, Ballesteros J, Aldama A, Pérez de Heredia JL, Gutierrez M, Mosquera F (2003) Principal components of mania. J Affect Disord 76(1–3):95–102

    Article  Google Scholar 

  37. Castro-Fornieles J, Parellada M, Gonzalez-Pinto A, Moreno D, Graell M, Baeza I et al (2007) The child and adolescent first-episode psychosis study (CAFEPS): design and baseline results. Schizophr Res 91(1–3):226–237

    Article  Google Scholar 

  38. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P et al (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36(7):980–988

    Article  CAS  Google Scholar 

  39. First M, Williams J, Karg R, Spitzer R (2015) Structured clinical interview for DSM-5—research version (SCID-5 for DSM-5, research version; SCID-5-RV). American Psychiatric Association, Arlington, VA

  40. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435

    Article  CAS  Google Scholar 

  41. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6(4):278–296

    Article  CAS  Google Scholar 

  42. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–276

    Article  CAS  Google Scholar 

  43. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H et al (1983) A children’s global assessment scale (CGAS). Arch Gen Psychiatry 40(11):1228–1231

    Article  CAS  Google Scholar 

  44. Cannon-Spoor HE, Potkin SG, Wyatt RJ (1982) Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 8(3):470–484

    Article  CAS  Google Scholar 

  45. IBM Corp (2012) IBM SPSS Statistics for Macintosh, version 21.0. Armonk, NY

  46. Dikeos DG, Wickham H, McDonald C, Walshe M, Sigmundsson T, Bramon E et al (2006) Distribution of symptom dimensions across Kraepelinian divisions. Br J Psychiatry 189:346–353

    Article  Google Scholar 

  47. Ventura J, Nuechterlein KH, Subotnik KL, Gutkind D, Gilbert EA (2000) Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale. Psychiatry Res 97(2–3):129–135

    Article  CAS  Google Scholar 

  48. Munoz-Negro JE, Ibanez-Casas I, de Portugal E, Ochoa S, Dolz M, Haro JM et al (2015) A dimensional comparison between delusional disorder, schizophrenia and schizoaffective disorder. Schizophr Res 169(1–3):248–254

    Article  Google Scholar 

  49. Salazar de Pablo G, Studerus E, Vaquerizo J, Irving J, Catalan A, Oliver D et al (2021) Implementing precision psychiatry: a systematic review of individualised prediction models. Schizophr Bull 47(2):284–297

    Article  Google Scholar 

  50. González-Pinto A, Aldama A, Pinto AG, Mosquera F, Pérez de Heredia JL, Ballesteros J et al (2004) Dimensions of mania: differences between mixed and pure episodes. Eur Psychiatry 19(5):307–310

    Article  Google Scholar 

  51. Martino DJ, Valerio MP, Parker G (2020) The structure of mania: an overview of factorial analysis studies. Eur Psychiatry 63(1):e10

    Article  Google Scholar 

  52. Schwartz-Stav O, Apter A, Zalsman G (2006) Depression, suicidal behavior and insight in adolescents with schizophrenia. Eur Child Adolesc Psychiatry 15(6):352–359

    Article  Google Scholar 

  53. Lysaker PH, Roe D, Yanos PT (2007) Toward understanding the insight paradox: internalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders. Schizophr Bull 33(1):192–199

    Article  Google Scholar 

  54. Harvey PD, Endicott JM, Loebel AD (2008) The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment. Bipolar Disord 10(8):900–906

    Article  Google Scholar 

  55. Rice F, Riglin L, Lomax T, Souter E, Potter R, Smith DJ et al (2019) Adolescent and adult differences in major depression symptom profiles. J Affect Disord 243:175–181

    Article  CAS  Google Scholar 

  56. Taylor D, Barnes TRE, Young AH (2018) The Maudsley prescribing guidelines, 13th edn. Sons JW

    Google Scholar 

  57. Giannitelli M, Levinson DF, Cohen D, Xavier J, Laurent-Levinson C, Mol Genetics Schizophrenia C (2020) Developmental and symptom profiles in early-onset psychosis. Schizophr Res 216:470–478

    Article  Google Scholar 

  58. Rutigliano G, Merlino S, Minichino A, Patel R, Davies C, Oliver D et al (2018) Long term outcomes of acute and transient psychotic disorders: the missed opportunity of preventive interventions. Eur Psychiatry 52:126–133

    Article  Google Scholar 

  59. Fusar-Poli P, Solmi M, Brondino N, Davies C, Chae C, Politi P et al (2019) Transdiagnostic psychiatry: a systematic review. World Psychiatry 18(2):192–207

    Article  Google Scholar 

  60. Etain B, Lajnef M, Loftus J, Henry C, Raust A, Gard S et al (2017) Association between childhood dimensions of attention deficit hyperactivity disorder and adulthood clinical severity of bipolar disorders. Aust N Z J Psychiatry 51(4):382–392

    Article  Google Scholar 

  61. Stanton K, Gruber J, Watson D (2017) Basic dimensions defining mania risk: a structural approach. Psychol Assess 29(3):304–319

    Article  Google Scholar 

  62. Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P (1995) A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Arch Gen Psychiatry 52(5):352–360

    Article  CAS  Google Scholar 

  63. Craddock KES, Zhou X, Liu S, Gochman P, Dickinson D, Rapoport JL (2018) Symptom dimensions and subgroups in childhood-onset schizophrenia. Schizophr Res 197:71–77

    Article  Google Scholar 

  64. Woodward TS, Jung K, Smith GN, Hwang H, Barr AM, Procyshyn RM et al (2014) Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosis. Eur Arch Psychiatry Clin Neurosci 264(8):673–682

    Article  Google Scholar 

  65. Reininghaus U, Priebe S, Bentall RP (2013) Testing the psychopathology of psychosis: evidence for a general psychosis dimension. Schizophr Bull 39(4):884–895

    Article  Google Scholar 

  66. Marques TR, Levine SZ, Reichenberg A, Kahn R, Derks EM, Fleischhacker WW et al (2014) How antipsychotics impact the different dimensions of Schizophrenia: a test of competing hypotheses. Eur Neuropsychopharmacol 24(8):1279–1288

    Article  CAS  Google Scholar 

Download references

Funding

This study has been supported by the Spanish Ministry of Science, Innovation, and Universities, Instituto de Salud Carlos III, European Regional Development Fund “A way of making Europe,” Centro de Investigación Biomédica en Red Salud Mental, Madrid Regional Government; Fundación Alicia Koplowtiz and Fundación Mutua Madrileña. GSP was supported by the Alicia Koplowitz Foundation. DM, CA, MR-C and CM were partially supported by the Spanish Ministry of Science and Innovation and the Instituto de Salud Carlos III (PI15/00723, PI17/02227, PI18/00753), co-financed by ERDF Funds from the European Commission, “A way of making Europe,” CIBERSAM, Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), European Union Structural Funds, European Union Seventh Framework Programme and European, Union Seventh Framework Program under grant agreements FP7-HEALTH-2009-2.2.1-2-241909 (Project EU-GEI), FP7-HEALTH-2009-2.2.1-3-242114 (Project OPTiMISE), FP7- HEALTH-2013-2.2.1-2-603196 (Project PSYSCAN) and FP7- HEALTH-2013- 2.2.1-2-602478 (Project METSY); and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (Grant Agreement No 115916, Project PRISM, and Grant Agreement No 777394, Project AIMS-2-TRIALS), Fundación Familia Alonso and Fundación Alicia Koplowitz and Fundación Mutua Madrileña. IB was supported by Instituto de Salud Carlos III (INT19/0021). MR-C was supported by a Ramon y Cajal Research Fellowship (RYC-2017-23144), Spanish Ministry of Science, Innovation and Universities and an NARSAD independent investigator grant (24628) from the Brain & Behavior Research Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marta Rapado-Castro.

Ethics declarations

Conflict of interest

GSP has received honoraria from Janssen Cilag. DM has received honoraria from Otsuka-Lundbeck. IB has received honoraria or travel support from Angelini, Janssen and Otsuka-Lundbeck. MG has received travel support from Shire and Otsuka-Lundbeck. CA has been a consultant to or has received honoraria or grants from Acadia, Angelini, Gedeon Richter, Janssen Cilag, Lundbeck, Otsuka, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion and Takeda. CM has been a consultant to or has received honoraria from Janssen, Angelini, Servier, Nuvelution, Otsuka, Lundbeck and Esteve.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 67 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salazar de Pablo, G., Moreno, D., Gonzalez-Pinto, A. et al. Affective symptom dimensions in early-onset psychosis over time: a principal component factor analysis of the Young Mania Rating Scale and the Hamilton Depression Rating Scale. Eur Child Adolesc Psychiatry 31, 1715–1728 (2022). https://doi.org/10.1007/s00787-021-01815-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00787-021-01815-5

Keywords

Navigation